Anti-Hypertensive Efficacy Of Combination Therapy Of Sarpagandha Vati With Anuloman Chikitsa (Haritaki Churna)” On Vyana Bala Vaishamya(~Hypertension)- Randomised Clinical Trial

Abstract

Hypertension is a common health problem that significantly raises the risk of heart disease, stroke, and kidney damage. Understanding it through both Ayurveda and modern medicine can offer more complete management strategies. In Ayurvedic thought, hypertension aligns with Vyana Bala Vaishamya, a condition in which Vyana Vayu—the dosha responsible for the circulation of blood and vital fluids—becomes unbalanced or overactive. This disturbance often involves aggravation of the Vata dosha, frequently also Pitta, which affects vascular health and blood flow.

Modern medicine defines hypertension by specific blood pressure thresholds. For instance, recent guidelines have set the cutoffs at around 130/80 mmHg for Stage 1 hypertension, with higher values defining more severe stages. Treatment involves both lifestyle changes (such as diet, exercise, stress reduction) and medications—diuretics, angiotensin receptor blockers, beta-blockers, calcium channel blockers, etc. Each of these works through different mechanisms (e.g. reducing fluid volume, lowering heart rate, relaxing vascular smooth muscle), but long-term use can lead to side effects, and patient adherence can be an issue.

This study demonstrates that hypertension (Vyana Bala Vaishamya) is heavily affected by both non-modifiable factors—such as age and family history—and modifiable ones, including levels of physical activity, sleep habits, and overall lifestyle. The study revealed that most patients exhibited moderate to mild symptom improvement, with significant decreases in both Diastolic and Systolic blood pressure measurements.  Furthermore, the Combination therapy of sarpagandha vati with anuloman chikitsa significantly mitigated mental health symptoms, including Anidra and Shirashoola, suggesting its viability as a therapeutic intervention for stress-induced hypertension.